Exploratory analysis of plasma cytokine/chemokine levels in 6-year-old children from a birth cohort study.

Asthma Atopic dermatitis Child Cohort study Machine learning

Journal

Cytokine
ISSN: 1096-0023
Titre abrégé: Cytokine
Pays: England
ID NLM: 9005353

Informations de publication

Date de publication:
06 Mar 2020
Historique:
received: 07 10 2019
revised: 11 01 2020
accepted: 21 02 2020
pubmed: 11 3 2020
medline: 11 3 2020
entrez: 11 3 2020
Statut: aheadofprint

Résumé

This study aimed to reveal a new dimension of allergy profiles in the general population by using machine learning to explore complex relationships among various cytokines/chemokines and allergic diseases (asthma and atopic dermatitis; AD). We examined the symptoms related to asthma and AD and the plasma levels of 72 cytokines/chemokines obtained from a general population of 161 children at 6 years of age who participated in a pilot birth cohort study of the Japan Environment and Children's Study (JECS). The children whose signs and symptoms fulfilled the criteria of AD, which are mostly based on questionnaire including past symptoms, tended to have higher levels of the two chemokine ligands, CCL17 and CCL27, which are used for diagnosis of AD. On the other hand, another AD-related chemokine CCL22 level in plasma was higher only in children with visible flexural eczema, which is one of AD diagnostic criteria but was judged on the same day of blood examination unlike other criteria. Here, we also developed an innovative method of machine learning for elucidating the complex cytokine/chemokine milieu related to symptoms of allergic diseases by using clustering analysis based on the random forest dissimilarity measure that relies on artificial intelligence (AI) technique. To our surprise, the majority of children showing at least any asthma-related symptoms during the last month were divided by AI into the two clusters, either cluster-2 having elevated levels of IL-33 (related to eosinophil activation) or cluster-3 having elevated levels of CXCL7/NAP2 (related to neutrophil activation), among the total three clusters. Future studies will clarify better approach for allergic diseases by endotype classification.

Identifiants

pubmed: 32151964
pii: S1043-4666(20)30067-3
doi: 10.1016/j.cyto.2020.155051
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155051

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Kiwako Yamamoto-Hanada (K)

Allergy Center, Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan; Medical Support Center for the Japan Environment and Children's Study, National Research Institute for Child Health and Development, Tokyo, Japan. Electronic address: yamamoto-k@ncchd.go.jp.

Eiryo Kawakami (E)

RIKEN Medical Sciences Innovation Hub Program, Kanagawa, Japan; Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

Mayako Saito-Abe (M)

Allergy Center, Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan; Medical Support Center for the Japan Environment and Children's Study, National Research Institute for Child Health and Development, Tokyo, Japan.

Miori Sato (M)

Allergy Center, Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan; Medical Support Center for the Japan Environment and Children's Study, National Research Institute for Child Health and Development, Tokyo, Japan.

Hiroshi Mitsubuchi (H)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kumamoto University, Kumamoto, Japan.

Masako Oda (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kumamoto University, Kumamoto, Japan.

Takahiko Katoh (T)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kumamoto University, Kumamoto, Japan.

Masafumi Sanefuji (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kyushu University, Fukuoka, Japan.

Shouichi Ohga (S)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kyushu University, Fukuoka, Japan.

Mari Kuwajima (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kyushu University, Fukuoka, Japan.

Nathan Mise (N)

Regional Center for Pilot Study of Japan Environment and Children's Study, Jichi Medical University, Tochigi, Japan.

Akihiko Ikegami (A)

Regional Center for Pilot Study of Japan Environment and Children's Study, Jichi Medical University, Tochigi, Japan.

Fujio Kayama (F)

Regional Center for Pilot Study of Japan Environment and Children's Study, Jichi Medical University, Tochigi, Japan.

Ayako Senju (A)

Regional Center for Pilot Study of Japan Environment and Children's Study, University of Occupational and Environmental Health, Fukuoka, Japan.

Masayuki Shimono (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, University of Occupational and Environmental Health, Fukuoka, Japan.

Koichi Kusuhara (K)

Regional Center for Pilot Study of Japan Environment and Children's Study, University of Occupational and Environmental Health, Fukuoka, Japan.

Shin Yamazaki (S)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Ibaraki, Japan.

Shoji F Nakayama (SF)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Ibaraki, Japan. Electronic address: fabre@nies.go.jp.

Kenji Matsumoto (K)

Allergy Center, Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

Hirohisa Saito (H)

Allergy Center, Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan; Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan.

Yukihiro Ohya (Y)

Allergy Center, Medical Support Center for the Japan Environment and Children's Study, National Center for Child Health and Development, Tokyo, Japan; Medical Support Center for the Japan Environment and Children's Study, National Research Institute for Child Health and Development, Tokyo, Japan.

Classifications MeSH